Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs ConocoPhillips (COP) Price & Performance

AbCellera Biologics IncTrade
ConocoPhillipsTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs ConocoPhillips — how do they compare? AbCellera Biologics Inc trades at $9.06 (market cap $2.99B), while ConocoPhillips trades at $124.95 (market cap $151.27B). The key difference: ConocoPhillips is far larger — about 50.6× AbCellera Biologics Inc's market cap, and ConocoPhillips pays a 2.67% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.

ABCLCOP
Market Cap
$2.99B$151.27B
Sector
HealthEnergy
52-Week High
$9.76$133.80
52-Week Low
$2.78$85.66
Enterprise Value
$2.58B$166.87B
Dividend Yield
2.67%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About ConocoPhillips

ConocoPhillips is a U.S.-based independent exploration and production firm. In 2021, it produced 1.0 million barrels per day of oil and natural gas liquids and 3.2 billion cubic feet per day of natural gas, primarily from Alaska and the Lower 48 in the United States and Norway in Europe and several countries in Asia-Pacific and the Middle East. Proven reserves at year-end 2021 were 6.1 billion barrels of oil equivalent.

Read more on COP